Immunosuppressed Patients with Clinically Diagnosed Invasive Fungal Infections: The Fungal Species Distribution, Antifungal Sensitivity and Associated Risk Factors in a Tertiary Hospital of Anhui Province

References

• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. doi:10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. doi:10.1126/scitranslmed.3004404
   PubMed Web of Science ®Google Scholar
• Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care. 2015;42(4):501–516. doi:10.1016/j.pop.2015.08.004
   PubMed Web of Science ®Google Scholar
• Pathakumari B, Liang G, Liu W. Immune defence to invasive fungal infections: a comprehensive review. Biomed Pharmacother. 2020;130:110550. doi:10.1016/j.biopha.2020.110550
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34(7):909–917. doi:10.1086/339202
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177–186. doi:10.1086/321811
   PubMed Web of Science ®Google Scholar
• Gorschluter M, Mey U, Strehl J, et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis. 2006;6:35. doi:10.1186/1471-2334-6-35
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu A. Emerging invasive fungal infections: clinical features and controversies in diagnosis and treatment processes. Infect Drug Resist. 2020;13:607–615. doi:10.2147/IDR.S237815
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Fungal infections in older adults. Clin Infect Dis. 2001;33(4):550–555. doi:10.1086/322685
   Web of Science ®Google Scholar
• Jenks JD, Cornely OA, Chen SC, Thompson GR 3rd, Hoenigl M. Breakthrough invasive fungal infections: who is at risk? Mycoses. 2020;63(10):1021–1032. doi:10.1111/myc.13148
   PubMed Web of Science ®Google Scholar
• Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol. 2002;81(5):233–243. doi:10.1007/s00277-002-0466-3
   Web of Science ®Google Scholar
• Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S. In-vitro antimicrobial activity of a new ophthalmic solution containing hexamidine diisethionate 0.05% (keratosept). Cornea. 2020;39(11):1415–1418. doi:10.1097/ICO.0000000000002375
   Web of Science ®Google Scholar
• Pinna A, Donadu MG, Usai D, et al. In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM®). Acta Ophthalmol. 2020;98(2):e178–e180. doi:10.1111/aos.14243
   Web of Science ®Google Scholar
• Raj N, Vanathi M, Ahmed NH, Gupta N, Lomi N, Tandon R. Recent perspectives in the management of fungal keratitis. J Fungi. 2021;7(11):907. doi:10.3390/jof7110907
   Web of Science ®Google Scholar
• Donadu MG, Peralta-Ruiz Y, Usai D, et al. Colombian essential oil of Ruta graveolens against nosocomial antifungal resistant Candida strains. J Fungi. 2021;7(5):383. doi:10.3390/jof7050383
   Web of Science ®Google Scholar
• Barac A, Donadu M, Usai D, et al. Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. Infection. 2018;46(2):253–257. doi:10.1007/s15010-017-1102-4
   PubMed Web of Science ®Google Scholar
• Bua A, Usai D, Donadu MG, et al. Antimicrobial activity of Austroeupatorium inulaefolium (H.B.K.) against intracellular and extracellular organisms. Nat Prod Res. 2018;32(23):2869–2871. doi:10.1080/14786419.2017.1385014
   PubMed Web of Science ®Google Scholar
• Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237–245. doi:10.2147/IDR.S118892
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445–S451. doi:10.1093/infdis/jix131
   PubMed Web of Science ®Google Scholar
• Society of Critical Care Medicine CMA. Guidelines for the diagnosis and treatment of invasive fungal infections in critically ill patients. Chin J Intern Med. 2007;46(11):960–966.
   Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Wang X, Liu P, Cao X. Genetic mutation of ERG11 and ERG3 and the relation between Candida and fluconazole resistance. Chin J Dermatovenereol. 2018;32(4):387–390.
   Google Scholar
• Jiang C, Dong D, Yu B, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778–785. doi:10.1093/jac/dks481
   PubMed Web of Science ®Google Scholar
• Von Lilienfeld-toal M, Wagener J, Einsele H, Cornely OA, Kurzai O. Invasive fungal infection. Dtsch Arztebl Int. 2019;116(16):271–278. doi:10.3238/arztebl.2019.0271
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/421946
   PubMed Web of Science ®Google Scholar
• Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;32(9):1319–1324. doi:10.1086/319985
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42(10):4419–4431. doi:10.1128/JCM.42.10.4419-4431.2004
   PubMed Web of Science ®Google Scholar
• Armstrong-James D, Youngs J, Bicanic T, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J. 2020;56(4):2002554. doi:10.1183/13993003.02554-2020
   PubMed Web of Science ®Google Scholar
• Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903. doi:10.2147/IDR.S299774
   PubMed Web of Science ®Google Scholar
• Wu Q, Xie X, Liu W, Wu Y. Implementation efficiency of the hierarchical diagnosis and treatment system in China: a case study of primary medical and health institutions in Fujian province. Int J Health Plann Manage. 2021;1–14. doi:10.1002/hpm.3333
   Web of Science ®Google Scholar
• Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in-vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42(4):1519–1527. doi:10.1128/JCM.42.4.1519-1527.2004
   PubMed Web of Science ®Google Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383–e392. doi:10.1016/S1473-3099(17)30316-X
   PubMed Web of Science ®Google Scholar
• Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine. 2000;79(4):250–260. doi:10.1097/00005792-200007000-00006
   PubMed Web of Science ®Google Scholar
• Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value Health. 2002;5(1):26–34. doi:10.1046/j.1524-4733.2002.51108.x
   PubMed Web of Science ®Google Scholar
• Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011;15(6):R287. doi:10.1186/cc10574
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792. doi:10.1016/S2213-2600(18)30274-1
   PubMed Web of Science ®Google Scholar
• Li H, Guo M, Wang C, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect. 2020;148:e169. doi:10.1017/S0950268820001624
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China hospital invasive fungal surveillance net (CHIF-NET) study. J Clin Microbiol. 2018;56(7). doi:10.1128/JCM.00577-18
   Web of Science ®Google Scholar
• Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med. 2013;10(11):e1001556. doi:10.1371/journal.pmed.1001556
   PubMed Web of Science ®Google Scholar
• Edwards JE Jr, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis. 1997;25(1):43–59. doi:10.1086/514504
   Web of Science ®Google Scholar
• Yinzhong S, Hongzhou L, Yongxin Z. Analysis of ERG11 gene mutations in fluconazole-resistant Candida glabrata strains. Chin J Infect Dis. 2010;28(6):331–335.
   Google Scholar
• Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 2016;4(5). doi:10.1128/microbiolspec.FUNK-0002-2016
   PubMed Web of Science ®Google Scholar
• Svetaz LA, Postigo A, Butassi E, Zacchino SA, Sortino MA. Antifungal drugs combinations: a patent review 2000–2015. Expert Opin Ther Pat. 2016;26(4):439–453. doi:10.1517/13543776.2016.1146693
   PubMed Web of Science ®Google Scholar
• Janeth Rimachi Hidalgo K, Carmello JC, Carolina Jordao C, et al. Antimicrobial photodynamic therapy in combination with nystatin in the treatment of experimental oral candidiasis induced by Candida albicans resistant to fluconazole. Pharmaceuticals. 2019;12(3):140. doi:10.3390/ph12030140
   Web of Science ®Google Scholar